Baron Small Cap Fund (BSCFX)

Portfolio Management

CliffGreenberg
Cliff Greenberg

Fund Manager since 1997

View All Commentary by Cliff

Fund Description

Baron Small Cap Fund invests primarily in small growth companies.

    

    

Fund Resources

side column img example
Cliff Greenberg seeks long-term growth from small companies.

Watch Video

Latest Fact Sheets

Standard Fact Sheet

Expanded Fact Sheet - Institutional Shares

Performance Attribution


 

Portfolio Commentary

Retail Performance

Review and Outlook (for quarter ended 6/30/2015)

The U.S. economy strengthened in the second quarter, after a weak first quarter when GDP was negatively affected by declining commodity prices and terrible weather.  Labor reports improved, both in jobs created and an acceleration in hourly wages, which was new.  Housing sales have picked up. Inflation remained muted. Stock deals were back to all-time high levels of activity, another strong support for the market. However, this positive merger and economic backdrop was counter-balanced by serious geopolitical issues (Greece, China, Iran, Puerto Rico) and concerns about the U.S. Federal Reserve raising interest rates. All in all, the market went sideways.

Baron Small Cap Fund decreased in the second quarter. Information Technology (IT) and Health Care were notable sector contributors to performance. Materials, Consumer Discretionary, and Industrials were the top detractors. Holdings in IT consulting & other services, systems software, and data processing & outsourced services helped boost performance of the IT sector. Application software holding ACI Worldwide, Inc. was also a notable contributor within the sector. Health Care benefited from the positive contribution of the Fund’s life sciences tools & services, managed health care, and health care equipment investments. Materials lost ground primarily due to the weak performance of Berry Plastics Group, Inc., which gave back some gains as packaged food volumes remained flat to down. With both the second biggest contributor, Bright Horizons Family Solutions, Inc., and the third biggest detractor, Iconix Brand Group, Inc., Consumer Discretionary had a mixed quarter, although detractors outweighed contributors. Industrials was negatively impacted by stock drops in short line railroad Genesee & Wyoming, Inc. and aerospace & defense company DigitalGlobe, Inc.

The market started the third quarter held hostage to events in Greece and China. After rejecting one austerity plan as too harsh, Greece reversed course and accepted an even harsher plan to remain in the European Union and reopen its banks. The Chinese stock market collapsed, declining by a third in a three-week period. The downdraft followed a 150% increase over the previous 12 months. The Chinese government is feverishly attempting to stop the sell-off, fearful that the $3 trillion lost as the bubble deflates could further depress the weakening economy.

The U.S. economy is improving since the weak first quarter, but still not showing robust growth. The winners in the small-cap growth arena were mostly high growth biotechnology and Information Technology companies. We are under-represented here since many of these businesses trade at very high valuations or are not making money at all, which is different than our historical valuation-conscious approach to investing.

We have favored investing in high quality businesses that we believe can significantly grow their profits and value over time. We are comfortable owning them even as those multiples have expanded as long as we see growth in the future, and we can stomach the current valuations. We continue our efforts to uncover our next long term growth companies and to monitor progress of our present holdings.

Top Contributors/Detractors to Performance

Contributors (for quarter ended 6/30/2015)
  • DexCom, Inc. sells a continuous glucose monitoring device for insulin-dependent diabetics. Shares rose on anticipation that sales will beat Street estimates based on the launch of the Share system, which allows others such as parents or spouses to receive the user’s blood glucose data from the user’s handheld device. Strong new patient starts in Q1, a ramp up in marketing spending, a rising probability that DexCom’s addressable market will include Medicare patients, and greater visibility on the company’s second generation products also helped boost share price.

  • Shares of corporate-sponsored childcare provider Bright Horizons Family Solutions, Inc. rose in Q2 as management continued its exceptional execution. Making up for 2014’s relatively slower acquisition pace, the company acquired 40 new centers in May. Growth has continued apace, driven by the rising center count, a mix shift to higher-margin consortium centers, greater capacity utilization, international expansion, and the rollout of new higher-margin offerings, including back-up care and education advisory services.

  • Shares of INC Research Holdings, Inc., a leading global contract research organization (CRO), providing outsourced drug development services to biopharma, advanced on strong Q1 results. Significant expansion of gross, operating, and adjusted EBITDA margins was especially standout. We believe the CRO industry backdrop is quite favorable, with the benefit of record biotech funding and a return to a more normalized pharma R&D spend accruing disproportionately to top global CROs such as INC.

Detractors (for quarter ended 6/30/2015)
  • Shares of United Natural Foods, Inc., the largest distributor of natural, organic, and specialty products to North American supermarkets, declined in Q2 on a slight deceleration in sales growth that we believe will prove temporary. The natural and organic food sector is one of the brightest categories within grocery, and United Natural has been the leader in getting these products to market. We are also excited about a recent acquisition that we believe could double the company’s addressable market opportunity in fresh and perishable foods.

  • After several quarters of strong performance, shares of veterinary diagnostics leader IDEXX Laboratories, Inc. fell in Q2. We attribute a portion of the stock’s decline to greater-than-expected foreign exchange headwinds. Separately, the company noted increased competition and lower prices, impacting around 3% of revenue. We believe management will respond successfully with pricing programs, creative diagnostic bundles, and an expanded inside sales force to better serve its customers.

  • Shares of brand licensing company Iconix Brand Group, Inc. fell on news that its COO and CFO were leaving the company. We believe their departures are not reflective of anything amiss at the company. We are believers in the ability of management to execute on the company’s growth plan and think the long-term fundamental prospects remain bright.

Quarterly Attribution Analysis (for quarter ended 6/30/2015)

When reviewing performance attribution on our portfolio, please be aware that we construct the portfolio from the bottom up, one stock at a time. Each stock is included in the portfolio if it meets our rigorous investment criteria. To help manage risk, we are aware of our sector and security weights, but we do not include a holding to achieve a target sector allocation or to approximate an index. Our exposure to any given sector is purely a result of our stock selection process.

Baron Small Cap Fund declined 1.39% in the second quarter and underperformed the Russell 2000 Growth Index by 337 basis points. The Fund’s stock selection and, to a lesser extent, relative sector weights detracted from relative performance. During the quarter, mid cap stocks lagged relative to small cap stocks and the Fund's exposure to the former as a result of its long-term investment approach also hurt relative performance.

Outperformance of Energy investments contributed the most to relative results, but this positive effect was partly offset by larger exposure to this lagging sector. Sector strength was mostly attributable to the outperformance of Scorpio Tankers, Inc., an oil and gas shipping company, and Valero Energy Partners LP, a high growth MLP formed by Valero Energy Corp. to own and operate its midstream assets. Shares of Scorpio rose due to improving product tanker shipping rates. Shares of Valero Energy performed well in the quarter despite  the weak energy market. The Fund increased its position with the view that the company’s growth was secured regardless of the commodity cycle, making it attractive to energy investors.

Health Care, Consumer Discretionary, and Materials investments were the primary detractors from relative results. Within Health Care, meaningfully lower exposure to biotechnology stocks, which rose 12.7% in the index, detracted 116 basis points from relative performance. Sector weakness was also attributable to the underperformance of IDEXX Laboratories, Inc., the second largest detractor on an absolute basis, and Brookdale Senior Living Inc., a senior housing provider. Brookdale’s shares lagged over concerns regarding its integration with Emeritus and business fundamentals. The Spectranetics Corporation, a medical device company that specializes in equipment that clears plaque from arteries, also detracted. Shares declined on missed revenues in Q1 and lowered full year guidance. Within Consumer Discretionary, underperformance of apparel accessories & luxury goods holdings, led by Iconix Brand Group, Inc. and Tumi Holdings, Inc., detracted the most from relative performance. Iconix was the third largest detractor from absolute performance, while Tumi’s shares fell on reports of a disappointing start to the year, driven by decreased demand in some international markets and the domestic wholesale channel. Within Materials, underperformance of Berry Plastics Group, Inc. and Globe Specialty Metals, Inc. and larger exposure to this declining sector weighed the most on relative results. Shares of Berry, a plastics packaging company, fell on flat-to-down packaged food volumes and lack of meaningful contribution to revenue of its Versalite cup, a replacement for Styrofoam. Shares of Globe Specialty declined due to direct exposure to the prices of silicon metal and silicon-based alloy, which both fell in North America.

Back to Top

Invest In Baron Funds Today

The prospective performance of the companies discussed herein is based on our internal analysis and reflect our opinions only. We cannot promise future returns and our opinions are a reflection of our best judgement at the time of publication. Our views are not intended as recommendations or investment advise to any person and are subject to chage at any time based on market and other conditions and Baron has no obligation to update them. Investing in the stock market is always risky. Current and future portfolio holdings in the Fund are subject to risk.

Source: FactSet PA.